Literature DB >> 29380820

Severity and Outcomes of Upper Gastrointestinal Bleeding With Bloody Vs. Coffee-Grounds Hematemesis.

Loren Laine1,2, Stig B Laursen3, Liam Zakko1, Harry R Dalton4, Jing H Ngu5, Michael Schultz6, Adrian J Stanley7.   

Abstract

OBJECTIVES: Numerous reviews indicate bloody hematemesis signifies more severe bleeding than coffee-grounds hematemesis. We assessed severity and outcomes related to bleeding symptoms in a prospective study.
METHODS: Consecutive patients presenting with hematemesis or melena were categorized as bloody emesis (N=1209), coffee-grounds emesis without bloody emesis (N=701), or melena without hematemesis (N=1069). We assessed bleeding severity (pulse, blood pressure) and predictors of outcome (hemoglobin, risk stratification scores) at presentation, and outcomes of bleeding episodes. The primary outcome was a composite of transfusion, intervention, or mortality.
RESULTS: Bloody and coffee-grounds emesis were similar in pulse ≥100 beats/min (35 vs. 37%), systolic blood pressure ≤100 mm Hg (12 vs. 12%), and hemoglobin ≤100 g/l (25 vs. 27%). Risk stratification scores were lower with bloody emesis. The composite end point was 34.7 vs. 38.2% for bloody vs. coffee-grounds emesis; mortality was 6.6 vs. 9.3%. Hemostatic intervention was more common (19.4 vs. 14.4%) with bloody emesis (due to a higher frequency of varices necessitating endoscopic therapy), as was rebleeding (7.8 vs. 4.5%). Outcomes were worse with hematemesis plus melena vs. isolated hematemesis for bloody (composite: 62.4 vs. 25.6%; hemostatic intervention: 36.5 vs. 13.8%) and coffee-grounds emesis (composite: 59.1 vs. 27.1%; hemostatic intervention: 26.4 vs. 8.1%).
CONCLUSIONS: Bloody emesis is not associated with more severe bleeding episodes at presentation or higher mortality than coffee-grounds emesis, but is associated with modestly higher rates of hemostatic intervention and rebleeding. Outcomes with hematemesis are worsened with concurrent melena. The presence of bloody emesis plus melena potentially could be considered in decisions regarding timing of endoscopy.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29380820     DOI: 10.1038/ajg.2018.5

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  22 in total

1.  Acute upper gastrointestinal haemorrhage in west of Scotland: case ascertainment study.

Authors:  O Blatchford; L A Davidson; W R Murray; M Blatchford; J Pell
Journal:  BMJ       Date:  1997-08-30

2.  Three-year prospective validation of a pre-endoscopic risk stratification in patients with acute upper-gastrointestinal haemorrhage.

Authors:  Ewen A Cameron; J Nick Pratap; Tracey J Sims; Simone Inman; Donna Boyd; Maureen Ward; Stephen J Middleton
Journal:  Eur J Gastroenterol Hepatol       Date:  2002-05       Impact factor: 2.566

Review 3.  Methodology for randomized trials of patients with nonvariceal upper gastrointestinal bleeding: recommendations from an international consensus conference.

Authors:  Loren Laine; Brennan Spiegel; Alaa Rostom; Paul Moayyedi; Ernst J Kuipers; Marc Bardou; Joseph Sung; Alan N Barkun
Journal:  Am J Gastroenterol       Date:  2009-12-22       Impact factor: 10.864

4.  Early indicators of prognosis in upper gastrointestinal hemorrhage.

Authors:  D A Corley; A M Stefan; M Wolf; E F Cook; T H Lee
Journal:  Am J Gastroenterol       Date:  1998-03       Impact factor: 10.864

5.  A simple risk score accurately predicts in-hospital mortality, length of stay, and cost in acute upper GI bleeding.

Authors:  John R Saltzman; Ying P Tabak; Brian H Hyett; Xiaowu Sun; Anne C Travis; Richard S Johannes
Journal:  Gastrointest Endosc       Date:  2011-09-10       Impact factor: 9.427

6.  Relationship of time to presentation after onset of upper GI bleeding with patient characteristics and outcomes: a prospective study.

Authors:  Loren Laine; Stig B Laursen; Harry R Dalton; Jing H Ngu; Michael Schultz; Adrian J Stanley
Journal:  Gastrointest Endosc       Date:  2017-04-07       Impact factor: 9.427

7.  International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding.

Authors:  Alan N Barkun; Marc Bardou; Ernst J Kuipers; Joseph Sung; Richard H Hunt; Myriam Martel; Paul Sinclair
Journal:  Ann Intern Med       Date:  2010-01-19       Impact factor: 25.391

8.  Nasogastric aspirate predicts high-risk endoscopic lesions in patients with acute upper-GI bleeding.

Authors:  Abdulrahman M Aljebreen; Carlo A Fallone; Alan N Barkun
Journal:  Gastrointest Endosc       Date:  2004-02       Impact factor: 9.427

9.  Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding.

Authors:  Alan Barkun; Marc Bardou; John K Marshall
Journal:  Ann Intern Med       Date:  2003-11-18       Impact factor: 25.391

10.  Comparison of risk scoring systems for patients presenting with upper gastrointestinal bleeding: international multicentre prospective study.

Authors:  Adrian J Stanley; Loren Laine; Harry R Dalton; Jing H Ngu; Michael Schultz; Roseta Abazi; Liam Zakko; Susan Thornton; Kelly Wilkinson; Cristopher J L Khor; Iain A Murray; Stig B Laursen
Journal:  BMJ       Date:  2017-01-04
View more
  2 in total

1.  Practice guidance for the use of terlipressin for liver cirrhosis-related complications.

Authors:  Xingshun Qi; Zhaohui Bai; Qiang Zhu; Gang Cheng; Yu Chen; Xiaowei Dang; Huiguo Ding; Juqiang Han; Lei Han; Yingli He; Fanpu Ji; Hongxu Jin; Bimin Li; Hongyu Li; Yiling Li; Zhiwei Li; Bang Liu; Fuquan Liu; Lei Liu; Su Lin; Dapeng Ma; Fanping Meng; Ruizhao Qi; Tianshu Ren; Lichun Shao; Shanhong Tang; Yufu Tang; Yue Teng; Chunhui Wang; Ran Wang; Yunhai Wu; Xiangbo Xu; Ling Yang; Jinqiu Yuan; Shanshan Yuan; Yida Yang; Qingchun Zhao; Wei Zhang; Yongping Yang; Xiaozhong Guo; Weifen Xie
Journal:  Therap Adv Gastroenterol       Date:  2022-05-18       Impact factor: 4.802

2.  External validation of Liaoning score for predicting esophageal varices in liver cirrhosis: a Chinese multicenter cross-sectional study.

Authors:  Qianqian Li; Yunhai Wu; Qiang Zhu; Fanping Meng; Su Lin; Bang Liu; Bimin Li; Shanhong Tang; Yida Yang; Yiling Li; Shanshan Yuan; Yu Chen; Xingshun Qi
Journal:  Ann Transl Med       Date:  2019-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.